0001562180-24-004436.txt : 20240528 0001562180-24-004436.hdr.sgml : 20240528 20240528160143 ACCESSION NUMBER: 0001562180-24-004436 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240523 FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Egan Dwight H CENTRAL INDEX KEY: 0001712187 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38148 FILM NUMBER: 24991621 MAIL ADDRESS: STREET 1: 4049 S. HIGHLAND DRIVE CITY: SALT LAKE CITY STATE: UT ZIP: 84124 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Co-Diagnostics, Inc. CENTRAL INDEX KEY: 0001692415 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 462609396 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4049 SOUTH HIGHLAND DRIVE CITY: SALT LAKE CITY STATE: UT ZIP: 84124 BUSINESS PHONE: 8012789769 MAIL ADDRESS: STREET 1: 4049 SOUTH HIGHLAND DRIVE CITY: SALT LAKE CITY STATE: UT ZIP: 84124 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-05-23 false 0001692415 Co-Diagnostics, Inc. CODX 0001712187 Egan Dwight H 2401 S. FOOTHILL DRIVE SUITE D SALT LAKE CITY UT 84109 true true false false Chief Executive Officer false Common Stock 2024-05-23 4 A false 138333.00 0.00 A 409214.00 D Common Stock 2024-05-23 4 D false 42008.00 1.09 D 367206.00 D Restricted Stock Unit 0.00 2024-05-23 4 M false 138333.00 0.00 D Common Stock 765833.00 627500.00 D Included in 125,000 restricted stock units awarded to the Reporting Person on August 12, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2021. Included in 275,000 restricted stock units awarded to the Reporting Person on June 6, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022. Included in 155,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 23, 2023. Included in 275,000 restricted stock units awarded to the Reporting Person on May 15, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2023. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. /s/ Dwight H. Egan 2024-05-28